Publications from Bioanalytical Symposiums and Meetings
Publications

Bioanalytical Symposiums and Meetings

Publications from BioAgilytix’s Expert Scientists

Explore the extensive list of publications from bioanalytical symposiums and meetings to which BioAgilytix’s scientists have contributed:


8th GCC: consolidated feedback to US FDA on the 2013 draft FDA guidance on bioanalytical method validation.
Bower J, Fast D, Garofolo F, Gouty D, et al. Bioanalysis. 2014;6(22):2957-63. doi: 10.4155/bio.14.287.
Access Here

7th GCC Insights: incurred samples use; fit-for-purpose validation, solution stability, electronic laboratory notebook and hyperlipidemic matrix testing.
Rocci M, Gouty D, et al. Bioanalysis. 2014 Oct; 6(20):2713-20. doi: 10.4155/bio.14.231.
Access Here

2013 White Paper on recent issues in bioanalysis: ‘hybrid’–the best of LBA and LCMS.
Stevenson L, Wright L, Losauro M, Gouty D, et al. Bioanalysis. 2013 Dec;5(23):2903-18. doi: 10.4155/bio.13.238. Epub 2013 Oct 10.
Access Here

Recommendations on biomarker bioanalytical method validation by GCC.
Hougton R, Gouty D, Losauro M, et al. Bioanalysis. 2012 Oct; 4(20):2439-46. doi: 10.4155/bio.12.197.
Access Here

Conference report: 6th GCC focus on LBA: critical reagents, positive controls and reference standards; specificity for endogenous compounds; biomarkers; biosimilars.
Nicholson R, Safavi A, Gouty D, et al Bioanalysis. 2012 Oct; 4(19):2335-42. doi: 10.4155/bio.12.213.
Access Here

Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC).
Lowes S, Safavi A, Gouty D, Wright L, et al Bioanalysis. 2012 Sep; 4(17):2117-26.
Access Here

Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine
Xu, D., Cobb, Witherspoon, S. M., Baines, A. T. (2013). Cancer Biology and Therapy, 14(6), 492–501. doi:10.4161/cbt.24343
Access Here

2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part3—LBA, Biomarkers and Immunogenicity)
Amaravadi, L., Song, A., Myler, H., Thway, T., Kirshner, S., Devanarayan, V., G Ni, Y., Garofolo, F., Birnboeck, H., Richards, S., Gupta, S., Luo, L., Kingsley, C., Salazar-Fontana, L., Fraser, S., Gorovits, B., Allinson, J., Barger, T., Chilewski, S., Scheel Fjording, M., Haidar, S., Islam, R., Jaitner, B., Kamerud, J., Katori, N., Krinos-Fiorotti, C., Lanham, D., Ma, M., McNally, J., Morimoto, A., Mytych, D., Nogueira da Costa, A., Papadimitriou, A., Pillutla, R., Ray, S., Safavi, A., Savoie, N., Schaefer, M., Shih, J., Smeraglia, J., Skelly, M. F., Spond, J., Staack, R.F., Stouffer, B., Tampal, N., Torri, A., Welink, J., Yang, T., Zoghbi, J. Bioanalysis 2015 Dec 4; 7 (24):3107-24. Epub 2015 Dec 4.
Access Here

Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC).
Lowes, S., Boterman, M., Doig, M., Breda, M., Jersey, J., Lelacheur, R., Shoup, R., Garofolo, F., Dumont, I., Martinez, S., Needham,S., Zimmer, J., Caturla, M.C., Couerbe, P., Maltas, J., Steffen, R., Petrilla, J., Safavi, A., Awaiye, K., Bhatti, M., Sheldon, C., Schiebl, C., Struwe, P., Turk, D., Sangster, T., Pattison, C., Fast, D., Goodwin, L., Kamerud, J., Dinan, A., Mamelak, D., Islam, R., Segers, R., John Lin, Z., Hillier, J., Garofolo, W., Folguera, L., Zimmer, D., Zimmermann, T., Pawula, M., Moussallie, M., de Souza Teixeira, L., Rocha, T., Allinson, J., Jardieu, P., Tang, D., Gouty, D., Wright, L., Truog, J., Lin, J., Yamashita, Y., Khan, M., Liu, Y., Xu, A., Lundberg, R., Cox, C., Breau, A., Hayes, R., Bigogno, C., Schoutsen, D., Dilger, C., Jonker, J., Bouhajib, M., Levesque, A., Gagnon-Carignan, S., Harman, J. Nicholson, R., Jenkins, R., Warren, M., Hung Lin, M., Karnik, S., De Boer, T., Houghton, R., Green, R., Demaio, W., Sable, R., Smith, K., Siethoff, C., Cojocaru, L., Allen, M., Reuschel, S., Pilar Gonzalez, P., Harter, T., Fatmi, S., Rock, M., Vija, J., Sayyarpour, F., Malone, M., Nowatzke, W., Best, S., Fang, X. Bioanalysis 2012 Sep;4 (17):2117-26
Access Here

2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 – LBA, biomarkers and immunogenicity).
Richards S, Amaravadi L, Pillutla R, Birnboeck H, Torri A, Cowan KJ, Papadimitriou A, Garofolo F, Satterwhite C, Piccoli S, Wu B, Krinos-Fiorotti C, Allinson J, Berisha F, Cocea L, Croft S, Fraser S, Galliccia F, Gorovits B, Gupta S, Gupta V, Haidar S, Hottenstein C, Ishii-Watabe A, Jani D, Kadavil J, Kamerud J, Kramer D, Litwin V, Lima Santos GM, Nelson R, Ni Y, Pedras-Vasconcelos J, Qiu Y, Rhyne P, Safavi A, Saito Y, Savoie N, Scheibner K, Schick E, Siguenza PY, Smeraglia J, Staack RF, Subramanyam M, Sumner G, Thway T, Uhlinger D, Ullmann M, Vitaliti A, Welink J, Whiting CC, Xue L, Zeng R. Bioanalysis. 2016 Dec;8(23):2475-2496.
Access Here

2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3–LBA, biomarkers and immunogenicity).
Amaravadi L, Song A, Myler H, Thway T, Kirshner S, Devanarayan V, Ni YG, Garofolo F, Birnboeck H, Richards S, Gupta S, Luo L, Kingsley C, Salazar-Fontana L, Fraser S, Gorovits B, Allinson J, Barger T, Chilewski S, Fjording MS, Haidar S, Islam R, Jaitner B, Kamerud J, Katori N, Krinos-Fiorotti C, Lanham D, Ma M, McNally J, Morimoto A, Mytych D, Nogueira da Costa A, Papadimitriou A, Pillutla R, Ray S, Safavi A, Savoie N, Schaefer M, Shih J, Smeraglia J, Skelly MF, Spond J, Staack RF, Stouffer B, Tampal N, Torri A, Welink J, Yang TY, Zoghbi J. Bioanalysis. 2015 Dec;7(24):3107-24.
Access Here

Speak to a Scientist




What would you like to discuss?

With whom will we be speaking?






I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.

Yes I confirm that I am over the age of 16 and I consent to communications from BioAgilytix.